Company news
Milestone Pharmaceuticals Inc. news in 2019
Milestone Pharmaceuticals Inc.'s news releases, calls and decks from 2019, newest first.
Milestone Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Clinical and Corporate Update
November 12, 2019
Milestone Pharmaceuticals Announces First Patient Enrolled in NODE-303 Open-label Safety Study of Etripamil in PSVT
October 2, 2019
Milestone Pharmaceuticals Announces Appointment of Amit Hasija as Chief Financial Officer and Executive Vice President of Corporate Development
September 9, 2019
Milestone Pharmaceuticals Provides Positive Regulatory Updates for Etripamil Pivotal Program in PSVT and Reports Second Quarter 2019 Financial Results
August 12, 2019
Decks in 2019
- Investor Presentation (December 2019)
Investor deck · 42 slides · Dec 17, 2019
- World Heart Congress (January 2019)
Conference · 19 slides · January 2019
- ISPOR 2019
Conference · 19 slides · 2019